Fulgent Genetics (FLGT) FCF Margin (2015 - 2026)

Fulgent Genetics has disclosed FCF Margin across 12 years of filings, most recently posting 2.66% for Q1 2026.

• FCF Margin for Q1 2026 came in at 2.66%, up 1512.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 47.67% (down 3686.0% YoY), and the FY2025 annual result was 38.49%, down 3170.0% from the prior year.
• FCF Margin came in at 2.66% for Q1 2026 at Fulgent Genetics, up from 24661.5% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 57.16% in Q1 2022 to a low of 24661.5% in Q4 2025.
• The 5-year median for FCF Margin is 3.82% (2026), against an average of 1539.66%.
• Peak annual rise in FCF Margin reached 3224 bps in 2025, while the deepest fall reached 2464469 bps in 2025.
• Fulgent Genetics' FCF Margin stood at 14.52% in 2022, then climbed by 16 bps to 16.77% in 2023, then slumped by 200 bps to 16.81% in 2024, then plunged by 146637 bps to 24661.5% in 2025, then jumped by 100 bps to 2.66% in 2026.
• The last three FCF Margin figures came in at 2.66% (Q1 2026), 24661.5% (Q4 2025), and 13.82% (Q3 2025), per Business Quant data.